University of Houston Receives $3 Million for Cancer Immunotherapy Biomarker Core
University of Houston receives $3 million grant for cancer immunotherapy biomarker core from Cancer Prevention & Research Institute of Texas. This investment showcases the commitment to innovative cancer research.
This news matters as it highlights the significant investment in cutting-edge cancer research at the University of Houston. The establishment of the biomarker core has the potential to make a transformative impact on cancer treatment and outcomes. It also underscores the importance of public and private sector collaboration in advancing medical research.
